359 related articles for article (PubMed ID: 23187048)
1. Neonatal abstinence syndrome: therapeutic interventions.
Sublett J
MCN Am J Matern Child Nurs; 2013 Mar; 38(2):102-7; quiz 107-9. PubMed ID: 23187048
[TBL] [Abstract][Full Text] [Related]
2. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
[TBL] [Abstract][Full Text] [Related]
3. Mothers on methadone: care in the NICU.
Maguire DJ
Neonatal Netw; 2013; 32(6):409-15. PubMed ID: 24195801
[TBL] [Abstract][Full Text] [Related]
4. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
5. Breastfeeding promotion for management of neonatal abstinence syndrome.
Pritham UA
J Obstet Gynecol Neonatal Nurs; 2013; 42(5):517-26. PubMed ID: 24020477
[TBL] [Abstract][Full Text] [Related]
6. Update on the pharmacologic management of neonatal abstinence syndrome.
Bio LL; Siu A; Poon CY
J Perinatol; 2011 Nov; 31(11):692-701. PubMed ID: 21869765
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic management of neonatal abstinence syndrome in a community hospital.
Napolitano A; Theophilopoulos D; Seng SK; Calhoun DA
Clin Obstet Gynecol; 2013 Mar; 56(1):193-201. PubMed ID: 23314713
[TBL] [Abstract][Full Text] [Related]
8. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
9. The opioid-exposed newborn: assessment and pharmacologic management.
Jansson LM; Velez M; Harrow C
J Opioid Manag; 2009; 5(1):47-55. PubMed ID: 19344048
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
11. Management of neonatal abstinence syndrome in the newborn nursery.
Artigas V
Nurs Womens Health; 2014 Dec; 18(6):509-14. PubMed ID: 25495971
[TBL] [Abstract][Full Text] [Related]
12. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
[TBL] [Abstract][Full Text] [Related]
13. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
14. Two newborns of heroin-addicted mothers suffering neonatal withdrawal syndrome.
Kale-Çekinmez E; Mutlu B; Yapıcıoğlu H; Ozlü F; Asker H; Mert K; Narlı N; Satar M
Turk J Pediatr; 2012; 54(4):421-4. PubMed ID: 23692726
[TBL] [Abstract][Full Text] [Related]
15. Interventions for the Treatment of Neonatal Abstinence Syndrome.
Cook CE; Fantasia HC
Nurs Womens Health; 2019 Aug; 23(4):357-365. PubMed ID: 31251931
[TBL] [Abstract][Full Text] [Related]
16. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
[TBL] [Abstract][Full Text] [Related]
18. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
20. Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.
Colombini N; Elias R; Busuttil M; Dubuc M; Einaudi MA; Bues-Charbit M
Pharm World Sci; 2008 Jun; 30(3):227-34. PubMed ID: 18008179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
